Skip to main content

Sildenafil and furosemide nanoparticles as a novel pharmacological treatment for acute renal failure in rats

Research Authors
Mahmoud S Sabra, Essmat AH Allam, Khaled M Ahmed Hassanein
Research Date
Research Department
Research Journal
Naunyn-Schmiedeberg's Archives of Pharmacology
Research Year
2025
Research Member
Research Abstract

Hospitalized patients often develop acute renal failure (ARF), which causes severe morbidity and death. This research investigates the potential renoprotective benefits of sildenafil and furosemide in glycerol-induced ARF, and measures kidney function metrics in response to nanoparticle versions of these medications. Inducing ARF is commonly done by injecting 50% glycerol intramuscularly. Rats underwent a 24-h period of dehydration and starvation before slaughter for renal function testing. We investigated urine analysis, markers of oxidative stress, histology of kidney tissue, immunohistochemistry analysis of caspase-3 and interleukin-1 beta (IL-1 β), kidney injury molecule-1 (KIM-1), and neutrophil gelatinase–associated lipocalin (NGAL), which are specific indicators of kidney tissue damage. The results of our study showed that the combination of sildenafil and furosemide, using both traditional and …